chr6-160706093-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000484367.5(PLG):​n.706G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 377,368 control chromosomes in the GnomAD database, including 10,689 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.21 ( 3911 hom., cov: 32)
Exomes 𝑓: 0.23 ( 6778 hom. )

Consequence

PLG
ENST00000484367.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0600

Publications

8 publications found
Variant links:
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Gene-Disease associations (from GenCC):
  • hypoplasminogenemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • angioedema, hereditary, 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 6-160706093-G-A is Benign according to our data. Variant chr6-160706093-G-A is described in ClinVar as [Benign]. Clinvar id is 1247104.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.285 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLGNM_000301.5 linkc.50-314G>A intron_variant Intron 1 of 18 ENST00000308192.14 NP_000292.1 P00747
PLGNM_001168338.1 linkc.50-314G>A intron_variant Intron 1 of 3 NP_001161810.1 Q5TEH5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLGENST00000308192.14 linkc.50-314G>A intron_variant Intron 1 of 18 1 NM_000301.5 ENSP00000308938.9 P00747

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31756
AN:
151986
Hom.:
3916
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.102
Gnomad AMI
AF:
0.222
Gnomad AMR
AF:
0.196
Gnomad ASJ
AF:
0.289
Gnomad EAS
AF:
0.00192
Gnomad SAS
AF:
0.101
Gnomad FIN
AF:
0.256
Gnomad MID
AF:
0.232
Gnomad NFE
AF:
0.288
Gnomad OTH
AF:
0.227
GnomAD4 exome
AF:
0.225
AC:
50690
AN:
225264
Hom.:
6778
Cov.:
0
AF XY:
0.216
AC XY:
25792
AN XY:
119280
show subpopulations
African (AFR)
AF:
0.0994
AC:
709
AN:
7130
American (AMR)
AF:
0.148
AC:
1346
AN:
9066
Ashkenazi Jewish (ASJ)
AF:
0.258
AC:
1681
AN:
6514
East Asian (EAS)
AF:
0.000401
AC:
5
AN:
12460
South Asian (SAS)
AF:
0.0980
AC:
3042
AN:
31046
European-Finnish (FIN)
AF:
0.260
AC:
3496
AN:
13468
Middle Eastern (MID)
AF:
0.245
AC:
216
AN:
882
European-Non Finnish (NFE)
AF:
0.282
AC:
37219
AN:
132176
Other (OTH)
AF:
0.238
AC:
2976
AN:
12522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1722
3444
5166
6888
8610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.209
AC:
31750
AN:
152104
Hom.:
3911
Cov.:
32
AF XY:
0.204
AC XY:
15173
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.102
AC:
4245
AN:
41510
American (AMR)
AF:
0.195
AC:
2985
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
1001
AN:
3466
East Asian (EAS)
AF:
0.00193
AC:
10
AN:
5184
South Asian (SAS)
AF:
0.101
AC:
489
AN:
4822
European-Finnish (FIN)
AF:
0.256
AC:
2700
AN:
10562
Middle Eastern (MID)
AF:
0.229
AC:
67
AN:
292
European-Non Finnish (NFE)
AF:
0.288
AC:
19579
AN:
67962
Other (OTH)
AF:
0.224
AC:
472
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1249
2499
3748
4998
6247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.246
Hom.:
624
Bravo
AF:
0.202
Asia WGS
AF:
0.0460
AC:
165
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
3.3
DANN
Benign
0.26
PhyloP100
-0.060
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4252066; hg19: chr6-161127125; API